Evidence map›Paper›PMID 17004120›Full record

ArticleJournal of autism and developmental disorders2007

Systematic screening for subtelomeric anomalies in a clinical sample of autism.

Thomas H Wassink, Molly Losh, Joseph Piven, Val C Sheffield, Elizabeth Ashley, Erik R Westin, Shivanand R Patil

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of autism and developmental disorders, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Thomas H WassinkDepartment of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. thomas-wassink@uiowa.edu
Molly Losh
Joseph Piven
Val C Sheffield
Elizabeth Ashley
Erik R Westin
Shivanand R Patil
NeuroDevelopment Center · USUniversity of Iowa · USHoward Hughes Medical Institute · US

Funding

Molecular Genetics of AutismR01NS043550 · NINDS · UNIVERSITY OF IOWA · PI WASSINK, THOMAS H. · 2002 to 2006
$1.7M
NIMH NIH HHS MH62123-01NINDS NIH HHS NS43550-01
6 · The paper itself

Abstract

High-resolution karyotyping detects cytogenetic anomalies in 5-10% of cases of autism. Karyotyping, however, may fail to detect abnormalities of chromosome subtelomeres, which are gene rich regions prone to anomalies. We assessed whether panels of FISH probes targeted for subtelomeres could detect abnormalities beyond those identified by karyotyping in 104 individuals with Pervasive Developmental Disorders (PDDs) drawn from a general clinical population. Four anomalies were detected by karyotyping, while no additional anomalies were detected by subtelomere FISH or by probes targeted for 15q11.2q13 or 22q11.2 in subgroups of our sample. We conclude that while karyotyping may be more broadly indicated for autism than previously supposed, subtelomere FISH appears less likely to be a useful screening tool for unselected PDD populations.

Indexed as

Chromosome AberrationsGenetic TestingAsperger SyndromeAutistic DisorderChildChild Development Disorders, PervasiveChromosome BandingDiagnosis, DifferentialFemaleGenotypeHumansIn Situ Hybridization, FluorescenceKaryotypingKlinefelter SyndromeMaleTelomere

Identifiers

PMID17004120
OpenAlexW1979098285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.